Masaya Takahashi

发表

Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy.

M. Meyerson, P. Jänne, H. Ji, 2007, Cancer cell.

Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.

M. Meyerson, A. Lowell, D. Tenen, 2008, Cancer research.

Unwarranted Administration of Acetylcholinesterase Inhibitors Can Impair Genioglossus and Diaphragm Muscle Function

N. L. Chamberlin, A. Malhotra, A. Jordan, 2007, Anesthesiology.

Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomas.

H. Ji, L. Chirieac, Kwok-Kin Wong, 2007, The Journal of clinical investigation.

HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy

M. Meyerson, H. Ji, H. Greulich, 2009, Proceedings of the National Academy of Sciences.

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

M. Meyerson, H. Greulich, L. Chirieac, 2008, Oncogene.

Three‐dimensional magnetic resonance microscopy of pulmonary solitary tumors in transgenic mice

D. Tenen, O. Kocher, B. Halmos, 2006, Magnetic resonance in medicine.

Multidetector-row Computed Tomographic Angiography of Thoracic and Abdominal Aortic Aneurysms: Comparison of Arterial Enhancement With 3 Different Doses of Contrast Material

S. Kanao, K. Togashi, Masaki Yamamuro, 2007, Journal of computer assisted tomography.

Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.

M. Meyerson, D. Tenen, H. Greulich, 2008, Cancer research.